Abstract
Ultrasonography for monitoring the response of malignant liver lesions to regional therapy offers several advantages. The instrument is easy to transport and can be used in intensive care units, so it is the procedure of choice within the first few days after invasive techniques, such as isolated liver perfusion, to demonstrate tumor response. Changes in size or in the sonomorphological pattern of liver lesions early after therapy indicate a therapeutic response. There are no data available on the sensitivity of ultrasonography for differentiating the necrotic and viable parts of the tumor. If information on the extent of tumor necrosis is crucial for decisions on further treatment of a patient, ultrasonography should be complemented with other techniques, such as fine-needle puncture or imaging techniques such as computed tomography, nuclear magnetic resonance, and single photon emission computed tomography. The contribution of more recent developments in ultrasonography, such as color Doppler analysis of intratumoral blood flow or three-dimensional ultrasonography, for monitoring tumor necrosis remains to be evaluated.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bleiberg H, Gerard B, Peetrons PH, Dodion P (1989) Measurements of response to chemotherapy using ultrasound in metastatic liver involvement. Eur J Cancer Clin Oncol 25: 857–859
Gilby ED, Taylor KJW (1975) Ultrasound monitoring of hepatic metastases during chemotherapy. BM J 1: 371–373
Görg C, Schwerk WB, Wolf M, Havemann K (1990) Prognostic value of response to chemotherapy using ultrasound in lung cancer with metastatic liver involvement. Bildgebung 57: 70–73
Hordijk ML, Kok TC, Wilson JHP, Mulder AH (1993) Assessment of response of esophageal carcinoma to induction chemotherapy. Endoscopy 25: 592–596
Krakamp B, Schmitz R, Knöpfle G, Leidig P (1990) Primäre und metastatische Lebertumore - Beurteilung der Tumorregression bzw. response unter regionaler Zytostase durch Sonographie und Feinnadelpunktionshistologie. Leber Magen Darm 3: 138–144
Liess H, Roth C, Umgelter A, Zoller WG (1994) Improvements in volumetric quantification of circumscribed hepatic lesions by three dimensional sonography. Z Gastroenterol 32: 488–492
Ohnishi K, Nomura F (1989) Ultrasonic Doppler studies of hepatocellular carcinoma and comparison with other hepatic focal lesions. Gastroenterology 97: 1489–1497
Shüna 5, Yasuda J, Muto H, Tagawa K, Unuma T, Ibukuro K, Inoue Y, Takanashi R (1987) Percutaneous ethanol injection in the treatment of liver neoplasms. AJR Am J Roentgenol 149: 949–952
Tanaka S, Kitamura T, Fujita M, Nakanishi K, Okuda S (1990) Color Doppler flow imaging of liver tumors. AJR Am J Roentgenol 154: 509–514
Tanaka S, Kitamura T, Fujita M, Kasugai H, Inoue A, Ishiguro S (1992) Small hepatocellular carcinoma: differentiation from adenomatous hyperplastic nodule with color Doppler flow imaging. Radiology 182: 161–165
Van der Woude H-J, Bloem JL, van Oostayen JA, Nooy MA, Taminiau AHM, Hermans J, Reynierse M, Hogendoorn PCW (1995) Treatment of high-grade bone sarcomas with neoadjuvant chemotherapy: the utility of sequential color Doppler sonography in predicting histopathological response. AJR Am J Roentgenol 165: 125–133
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Gross, M., Zoller, W.G. (1998). Role of Ultrasonography for Monitoring Tumor Necrosis After Chemotherapy. In: Oldhafer, K.J., Lang, H., Pichlmayr, R. (eds) Isolated Liver Perfusion for Hepatic Tumors. Recent Results in Cancer Research, vol 147. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80460-1_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-80460-1_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-80462-5
Online ISBN: 978-3-642-80460-1
eBook Packages: Springer Book Archive